Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.4 USD | +2.53% | -3.19% | -10.81% |
05:34pm | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.81% | 8.84B | |
-4.16% | 184B | |
-2.60% | 107B | |
-5.33% | 67.52B | |
+0.84% | 50.06B | |
+9.83% | 45.67B | |
+3.40% | 41B | |
+3.17% | 26.73B | |
+3.99% | 26.47B | |
+15.23% | 25.05B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- RBC Raises Price Target on Repligen to $225 From $200, Keeps Outperform Rating